The future for computational modelling and prediction systems in clinical immunology

Nikolai Petrovsky, Diego Silva, Vladimir Brusic

Research output: Chapter in Book/Report/Conference proceedingChapter

3 Citations (Scopus)

Abstract

Advances in computational science, despite their enormous potential, have been surprisingly slow to impact on clinical practice. This paper examines the potential of bioinformatics to advance clinical immunology across a number of key examples including the use of computational immunology to improve renal transplantation outcomes, identify novel genes involved in immunological disorders, decipher the relationship between antigen presentation pathways and human disease, and predict allergenicity. These examples demonstrate the enormous potential for immunoinformatics to advance clinical and experimental immunology. The acceptance of immunoinformatic techniques by clinical and research immunologists will need robust standards of data quality, system integrity and properly validated immunoinformatic systems. Such validation, at a minimum, will require appropriately designed clinical studies conducted according to Good Clinical Practice standards. This strategy will enable immunoinformatics to achieve its full potential to advance and shape clinical immunology in the future.

Original languageEnglish
Title of host publicationNovartis Foundation Symposium
Pages23-42
Number of pages20
Volume254
Publication statusPublished - 2003
Externally publishedYes

Publication series

NameNovartis Foundation Symposium
Volume254

Fingerprint

Allergy and Immunology
Antigen Presentation
Computational Biology
Information Systems
Kidney Transplantation
Research Design
Genes

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Petrovsky, N., Silva, D., & Brusic, V. (2003). The future for computational modelling and prediction systems in clinical immunology. In Novartis Foundation Symposium (Vol. 254, pp. 23-42). (Novartis Foundation Symposium; Vol. 254).

The future for computational modelling and prediction systems in clinical immunology. / Petrovsky, Nikolai; Silva, Diego; Brusic, Vladimir.

Novartis Foundation Symposium. Vol. 254 2003. p. 23-42 (Novartis Foundation Symposium; Vol. 254).

Research output: Chapter in Book/Report/Conference proceedingChapter

Petrovsky, N, Silva, D & Brusic, V 2003, The future for computational modelling and prediction systems in clinical immunology. in Novartis Foundation Symposium. vol. 254, Novartis Foundation Symposium, vol. 254, pp. 23-42.
Petrovsky N, Silva D, Brusic V. The future for computational modelling and prediction systems in clinical immunology. In Novartis Foundation Symposium. Vol. 254. 2003. p. 23-42. (Novartis Foundation Symposium).
Petrovsky, Nikolai ; Silva, Diego ; Brusic, Vladimir. / The future for computational modelling and prediction systems in clinical immunology. Novartis Foundation Symposium. Vol. 254 2003. pp. 23-42 (Novartis Foundation Symposium).
@inbook{2fae3bc143dc4d5a95634e73f1259543,
title = "The future for computational modelling and prediction systems in clinical immunology",
abstract = "Advances in computational science, despite their enormous potential, have been surprisingly slow to impact on clinical practice. This paper examines the potential of bioinformatics to advance clinical immunology across a number of key examples including the use of computational immunology to improve renal transplantation outcomes, identify novel genes involved in immunological disorders, decipher the relationship between antigen presentation pathways and human disease, and predict allergenicity. These examples demonstrate the enormous potential for immunoinformatics to advance clinical and experimental immunology. The acceptance of immunoinformatic techniques by clinical and research immunologists will need robust standards of data quality, system integrity and properly validated immunoinformatic systems. Such validation, at a minimum, will require appropriately designed clinical studies conducted according to Good Clinical Practice standards. This strategy will enable immunoinformatics to achieve its full potential to advance and shape clinical immunology in the future.",
author = "Nikolai Petrovsky and Diego Silva and Vladimir Brusic",
year = "2003",
language = "English",
volume = "254",
series = "Novartis Foundation Symposium",
pages = "23--42",
booktitle = "Novartis Foundation Symposium",

}

TY - CHAP

T1 - The future for computational modelling and prediction systems in clinical immunology

AU - Petrovsky, Nikolai

AU - Silva, Diego

AU - Brusic, Vladimir

PY - 2003

Y1 - 2003

N2 - Advances in computational science, despite their enormous potential, have been surprisingly slow to impact on clinical practice. This paper examines the potential of bioinformatics to advance clinical immunology across a number of key examples including the use of computational immunology to improve renal transplantation outcomes, identify novel genes involved in immunological disorders, decipher the relationship between antigen presentation pathways and human disease, and predict allergenicity. These examples demonstrate the enormous potential for immunoinformatics to advance clinical and experimental immunology. The acceptance of immunoinformatic techniques by clinical and research immunologists will need robust standards of data quality, system integrity and properly validated immunoinformatic systems. Such validation, at a minimum, will require appropriately designed clinical studies conducted according to Good Clinical Practice standards. This strategy will enable immunoinformatics to achieve its full potential to advance and shape clinical immunology in the future.

AB - Advances in computational science, despite their enormous potential, have been surprisingly slow to impact on clinical practice. This paper examines the potential of bioinformatics to advance clinical immunology across a number of key examples including the use of computational immunology to improve renal transplantation outcomes, identify novel genes involved in immunological disorders, decipher the relationship between antigen presentation pathways and human disease, and predict allergenicity. These examples demonstrate the enormous potential for immunoinformatics to advance clinical and experimental immunology. The acceptance of immunoinformatic techniques by clinical and research immunologists will need robust standards of data quality, system integrity and properly validated immunoinformatic systems. Such validation, at a minimum, will require appropriately designed clinical studies conducted according to Good Clinical Practice standards. This strategy will enable immunoinformatics to achieve its full potential to advance and shape clinical immunology in the future.

UR - http://www.scopus.com/inward/record.url?scp=1342289628&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1342289628&partnerID=8YFLogxK

M3 - Chapter

VL - 254

T3 - Novartis Foundation Symposium

SP - 23

EP - 42

BT - Novartis Foundation Symposium

ER -